US tariffs on patented drugs may have limited immediate impact on India, but industry flags uncertainty as policy ties relief to pricing and manufacturing shifts
The US has announced a 100 per cent tariff on patented pharma imports from countries like India without reshoring deals, aiming to boost local production, while generics have been exempted for now
India and the US are set to clash over WTO reforms ahead of the MC14 meeting, with New Delhi defending core principles like consensus decision-making and the MFN rule
India remains engaged with the US side for a mutually beneficial trade deal, says Commerce Secretary Rajesh Agrawal, as negotiations continue on tariff changes and non-tariff barriers
After the courts blocked earlier tariffs, the Trump administration turns to Section 301 probes to justify new duties-putting India and other major trading partners under scrutiny
The US Trade Representative has launched an unfair trade practices probe into 60 countries, including India, alleging failure to block imports of goods produced using forced labour
USTR opens Section 301 investigations into 16 economies, including India, over excess manufacturing capacity that Washington says undermines US industrial revival
Goyal said India is closely watching the evolving situation following the US SC's verdict, and will continue to engage with Washington for best possible opportunities in the interim trade deal
USTR says India will determine within six months of the interim pact coming into force whether US or international standards are acceptable for select sectors, easing market access for US exports
India is closely watching US tariff moves after the Supreme Court verdict, with Goyal saying New Delhi will continue to engage Washington to preserve balance in the newly finalised interim trade deal
Exports from some EBRD countries to the United States even grew, particularly those related to the AI boom, as those countries replaced China's exports
The administration announced that a 10 per cent levy would be imposed beginning Tuesday morning, which Trump subsequently threatened to increase to 15 per cent
With the Supreme Court striking down Trump's use of IEEPA for tariffs, the former president may rely on older trade statutes to revive tariff action. Each carries implications for India